EssilorLuxottica Unsponsored ADR (OTCMKTS:ESLOY) Short Interest Up 295.3% in April

Posted by Donna Armstrong on May 15th, 2026

EssilorLuxottica Unsponsored ADR (OTCMKTS:ESLOY – Get Free Report) was the recipient of a significant increase in short interest in the month of April. As of April 30th, there was short interest totaling 20,151 shares, an increase of 295.3% from the April 15th total of 5,098 shares. Currently, 0.0% of the shares of the company are sold short. Based on an average daily volume of 301,668 shares, the short-interest ratio is presently 0.1 days.

EssilorLuxottica Trading Up 0.3%

Shares of ESLOY stock traded up $0.32 during midday trading on Friday, reaching $100.68. 32,037 shares of the company traded hands, compared to its average volume of 118,921. The firm’s 50 day simple moving average is $113.54 and its two-hundred day simple moving average is $145.82. EssilorLuxottica has a 1-year low of $96.56 and a 1-year high of $186.81. The company has a debt-to-equity ratio of 0.17, a current ratio of 0.99 and a quick ratio of 0.70.

Analysts Set New Price Targets

A number of equities research analysts recently commented on ESLOY shares. Kepler Capital Markets upgraded shares of EssilorLuxottica from a “hold” rating to a “buy” rating in a research report on Thursday, January 15th. Deutsche Bank Aktiengesellschaft initiated coverage on shares of EssilorLuxottica in a research report on Tuesday. They set a “hold” rating for the company. Two analysts have rated the stock with a Strong Buy rating, five have issued a Buy rating and two have issued a Hold rating to the company. Based on data from MarketBeat.com, EssilorLuxottica presently has a consensus rating of “Buy”.

View Our Latest Research Report on ESLOY

About EssilorLuxottica

(Get Free Report)

EssilorLuxottica SE is a global ophthalmic optics company formed through the 2018 merger of France-based Essilor and Italy-based Luxottica. Headquartered near Paris, the company combines lens manufacturing, frame design and production, brand management and retail operations to provide a vertically integrated offering across the vision care value chain. Its activities span product research and development, manufacturing, wholesale distribution and retailing of spectacles, sunglasses and ophthalmic lenses.

The company’s product portfolio includes prescription and non-prescription lenses, lens coatings and treatments, and an array of eyewear brands and frames.